Article

You have full text access to this OnlineOpen article

Elucidation of the stability and functional regions of the human coronavirus OC43 nucleocapsid protein†

  1. Chun-Yu Huang1,2,3,
  2. Yen-Lan Hsu4,
  3. Wan-Ling Chiang5,
  4. Ming-Hon Hou1,2,3,*

Article first published online: 18 AUG 2009

DOI: 10.1002/pro.225

Issue

Protein Science

Protein Science

Volume 18, Issue 11, pages 2209–2218, November 2009

Additional Information

How to Cite

Huang, C.-Y., Hsu, Y.-L., Chiang, W.-L. and Hou, M.-H. (2009), Elucidation of the stability and functional regions of the human coronavirus OC43 nucleocapsid protein. Protein Science, 18: 2209–2218. doi: 10.1002/pro.225

Author Information

  1. 1

    Biotechnology Center, National Chung Hsing University, Taichung 402, Taiwan

  2. 2

    Institute of Genomics and Bioinformatics, National Chung Hsing University, Taichung 402, Taiwan

  3. 3

    Department of Life Science, National Chung Hsing University, Taichung 402, Taiwan

  4. 4

    Institute of Biomedical Science, Academia Sinica, Taipei 115, Taiwan

  5. 5

    Institute of Biochemistry, National Chung Hsing University, Taichung 402, Taiwan

*Institute of Genomics and Bioinformatics, National Chung Hsing University, Taichung 402, Taiwan

  1. †

    The Symposium of the Protein Society and Experimental Biology Annual Meeting.

Publication History

  1. Issue published online: 23 OCT 2009
  2. Article first published online: 18 AUG 2009
  3. Accepted manuscript online: 18 AUG 2009 12:00AM EST
  4. Manuscript Accepted: 10 AUG 2009
  5. Manuscript Revised: 6 AUG 2009
  6. Manuscript Received: 2 JUL 2009

Funded by

  • NCS. Grant Number: 97-2311-B-005-003-MY3

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (468K)

References

  • 1
    St-Jean JR, Jacomy H, Desforges M, Vabret A, Freymuth F, Talbot PJ ( 2004) Human respiratory coronavirus OC43: genetic stability and neuroinvasion. J Virol 78: 8824–8834.
  • 2
    Vabret A, Mourez T, Gouarin S, Petitjean J, Freymuth F ( 2003) An outbreak of coronavirus OC43 respiratory infection in Normandy. Fr Clin Infect Dis 36: 985–989.
  • 3
    El-Sahly HM, Atmar RL, Glezen WP, Greenberg SB ( 2000) Spectrum of clinical illness in hospitalized patients with “common cold” virus infections. Clin Infect Dis 31: 96–100.
  • 4
    Gagneur A, Sizun J, Vallet S, Legr MC, Picard B, Talbot PJ ( 2002) Coronavirus-related nosocomial viral respiratory infections in a neonatal and paediatric intensive care unit: a prospective study. J Hosp Infect 51: 59–64.
  • 5
    Wenzel RP, Hendley JO, Davies JA, Gwaltney JM, Jr ( 1974) Coronavirus infections in military recruits. Three-year study with coronavirus strains OC43 and 229E. Am Rev Respir Dis 109: 621–624.
  • 6
    Arbour N, Day R, Newcombe J, Talbot PJ ( 2000) Neuroinvasion by human respiratory coronaviruses. J Virol 74: 8913–8921.
  • 7
    Leng Q, Bentwich Z ( 2003) A novel coronavirus and SARS. N Engl J Med 349: 709.
  • 8
    Hogue BG, Brian DA ( 1986) Structural proteins of human respiratory coronavirus OC43. Virus Res 5: 131–144.
  • 9
    Lai MM, Cavanagh D ( 1997) The molecular biology of coronaviruses. Adv Virus Res 48: 1–100.
  • 10
    Hiscox JA ( 2007) RNA viruses: hijacking the dynamic nucleolus. Nat Rev Microbiol 5: 119–127.
  • 11
    You JH, Reed ML, Dove BK, Hiscox JA ( 2006) Three-dimensional reconstruction of the nucleolus using meta-confocal microscopy in cells expressing the coronavirus nucleoprotein. Adv Exp Med Biol 581: 313–318.
  • 12
    Stohlman SA, Fleming JO, Patton CD, Lai MM ( 1983) Synthesis and subcellular localization of the murine coronavirus nucleocapsid protein. Virology 130: 527–532.
  • 13
    Masters PS, Parker MM, Ricard CS, Duchala C, Frana MF, Holmes KV, Sturman LS ( 1990) Structure and function studies of the nucleocapsid protein of mouse hepatitis virus. Adv Exp Med Biol 276: 239–246.
  • 14
    Masters PS, Sturman LS ( 1990) Background paper. Functions of the coronavirus nucleocapsid protein. Adv Exp Med Biol 276: 235–238.
  • 15
    Pyrc K, Jebbink MF, Berkhout B, Van Der Hoek L ( 2004) Genome structure and transcriptional regulation of human coronavirus NL63. Virol J 1: 7.
  • 16
    Baric RS, Nelson GW, Fleming JO, Deans RJ, Keck JG, Casteel N, Stohlman SA ( 1988) Interactions between coronavirus nucleocapsid protein and viral RNAs: implications for viral transcription. J Virol 62: 4280–4287.
  • 17
    Tang TK, Wu MP, Chen ST, Hou MH, Hong MH, Pan FM, Yu HM, Chen JH, Yao CW, Wang AH ( 2005) Biochemical and immunological studies of nucleocapsid proteins of severe acute respiratory syndrome and 229E human coronaviruses. Proteomics 5: 925–937.
  • 18
    Hsieh PK, Chang SC, Huang CC, Lee TT, Hsiao CW, Kou YH, Chen IY, Chang CK, Huang TH, Chang MF ( 2005) Assembly of severe acute respiratory syndrome coronavirus RNA packaging signal into virus-like particles is nucleocapsid dependent. J Virol 79: 13848–13855.
  • 19
    Kopecky-Bromberg SA, Martinez-Sobrido L, Frieman M, Baric RA, Palese P ( 2007) Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J Virol 81: 548–557.
  • 20
    Du L, Zhao G, Lin Y, Chan C, He Y, Jiang S, Wu C, Jin DY, Yuen KY, Zhou Y, Zheng BJ ( 2008) Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection. Vaccine 26: 1644–1651.
  • 21
    Surjit M, Liu B, Chow VT, Lal SK ( 2006) The nucleocapsid protein of severe acute respiratory syndrome-coronavirus inhibits the activity of cyclin-cyclin-dependent kinase complex and blocks S phase progression in mammalian cells. J Biol Chem 281: 10669–10681.
  • 22
    Zuniga S, Sola I, Moreno JL, Sabella P, Plana-Duran J, Enjuanes L ( 2007) Coronavirus nucleocapsid protein is an RNA chaperone. Virology 357: 215–227.
  • 23
    Chan KH, Cheng VC, Woo PC, Lau SK, Poon LL, Guan Y, Seto WH, Yuen KY, Peiris JS ( 2005) Serological responses in patients with severe acute respiratory syndrome coronavirus infection and cross-reactivity with human coronaviruses 229E, OC43, and NL63. Clin Diagn Lab Immunol 12: 1317–1321.
  • 24
    Mourez T, Vabret A, Han Y, Dina J, Legrand L, Corbet S, Freymuth F ( 2007) Baculovirus expression of HCoV-OC43 nucleocapsid protein and development of a Western blot assay for detection of human antibodies against HCoV-OC43. J Virol Methods 139: 175–180.
  • 25
    Chen CY, Chang CK, Chang YW, Sue SC, Bai HI, Riang L, Hsiao CD, Huang TH ( 2007) Structure of the SARS coronavirus nucleocapsid protein RNA-binding dimerization domain suggests a mechanism for helical packaging of viral RNA. J Mol Biol 368: 1075–1086.
  • 26
    Fan H, Ooi A, Tan YW, Wang S, Fang S, Liu DX, Lescar J ( 2005) The nucleocapsid protein of coronavirus infectious bronchitis virus: crystal structure of its N-terminal domain and multimerization properties. Structure 13: 1859–1868.
  • 27
    Jayaram H, Fan H, Bowman BR, Ooi A, Jayaram J, Collisson EW, Lescar J, Prasad BV ( 2006) X-ray structures of the N- and C-terminal domains of a coronavirus nucleocapsid protein: implications for nucleocapsid formation. J Virol 80: 6612–6620.
  • 28
    Nelson GW, Stohlman SA ( 1993) Localization of the RNA-binding domain of mouse hepatitis virus nucleocapsid protein. J Gen Virol 74 (Part 9): 1975–1979.
  • 29
    Spencer KA, Hiscox JA ( 2006) Characterisation of the RNA binding properties of the coronavirus infectious bronchitis virus nucleocapsid protein amino-terminal region. FEBS Lett 580: 5993–5998.
  • 30
    Chang CK, Sue SC, Yu TH, Hsieh CM, Tsai CK, Chiang YC, Lee SJ, Hsiao HH, Wu WJ, Chang WL, Lin CH, Huang TH ( 2006) Modular organization of SARS coronavirus nucleocapsid protein. J Biomed Sci 13: 59–72.
  • 31
    Masters PS ( 1992) Localization of an RNA-binding domain in the nucleocapsid protein of the coronavirus mouse hepatitis virus. Arch Virol 125: 141–160.
  • 32
    Peng D, Koetzner CA, Mcmahon T, Zhu Y, Masters PS ( 1995) Construction of murine coronavirus mutants containing interspecies chimeric nucleocapsid proteins. J Virol 69: 5475–5484.
  • 33
    Spencer KA, Dee M, Britton P, Hiscox JA ( 2008) Role of phosphorylation clusters in the biology of the coronavirus infectious bronchitis virus nucleocapsid protein. Virology 370: 373–381.
  • 34
    Chen H, Gill A, Dove BK, Emmett SR, Kemp CF, Ritchie MA, Dee M, Hiscox JA ( 2005) Mass spectroscopic characterization of the coronavirus infectious bronchitis virus nucleoprotein and elucidation of the role of phosphorylation in RNA binding by using surface plasmon resonance. J Virol 79: 1164–1179.
  • 35
    Yu IM, Oldham ML, Zhang J, Chen J ( 2006) Crystal structure of the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein dimerization domain reveals evolutionary linkage between corona- and arteriviridae. J Biol Chem 281: 17134–17139.
  • 36
    Saikatendu KS, Joseph JS, Subramanian V, Neuman BW, Buchmeier MJ, Stevens RC, Kuhn P ( 2007) Ribonucleocapsid formation of severe acute respiratory syndrome coronavirus through molecular action of the N-terminal domain of N protein. J Virol 81: 3913–3921.
  • 37
    Takeda M, Chang CK, Ikeya T, Guntert P, Chang YH, Hsu YL, Huang TH, Kainosho M ( 2008) Solution structure of the c-terminal dimerization domain of SARS coronavirus nucleocapsid protein solved by the SAIL-NMR method. J Mol Biol 380: 608–622.
  • 38
    Kamahora T, Soe LH, Lai MM ( 1989) Sequence analysis of nucleocapsid gene and leader RNA of human coronavirus OC43. Virus Res 12: 1–9.
  • 39
    Bolen DW, Santoro MM ( 1988) Unfolding free energy changes determined by the linear extrapolation method. II. Incorporation of delta G degrees N-U values in a thermodynamic cycle. Biochemistry 27: 8069–8074.
  • 40
    Wang Y, Zhang X ( 2000) The leader RNA of coronavirus mouse hepatitis virus contains an enhancer-like element for subgenomic mRNA transcription. J Virol 74: 10571–10580.
  • 41
    Sawicki SG, Sawicki DL, Siddell SG ( 2007) A contemporary view of coronavirus transcription. J Virol 81: 20–29.
  • 42
    Nelson GW, Stohlman SA, Tahara SM ( 2000) High affinity interaction between nucleocapsid protein and leader/intergenic sequence of mouse hepatitis virus RNA. J Gen Virol 81: 181–188.
  • 43
    Welter LM, Stohlman SA, Deans RJ ( 1990) MHV leader RNA secondary structure affects binding to the nucleocapsid protein. Adv Exp Med Biol 276: 247–254.
  • 44
    Yu IM, Gustafson CL, Diao J, Burgner JW, Li Z, Zhang J, Chen J ( 2005) Recombinant severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein forms a dimer through its C-terminal domain. J Biol Chem 280: 23280–23286.
  • 45
    Wang Y, Wu X, Wang Y, Li B, Zhou H, Yuan G, Fu Y, Luo Y ( 2004) Low stability of nucleocapsid protein in SARS virus. Biochemistry 43: 11103–11108.
  • 46
    Mohandas DV, Dales S ( 1991) Endosomal association of a protein phosphatase with high dephosphorylating activity against a coronavirus nucleocapsid protein. FEBS Lett 282: 419–424.
  • 47
    Huang Q, Yu L, Petros AM, Gunasekera A, Liu Z, Xu N, Hajduk P, Mack J, Fesik SW, Olejniczak ET ( 2004) Structure of the N-terminal RNA-binding domain of the SARS CoV nucleocapsid protein. Biochemistry 43: 6059–6063.
  • 48
    Lin S, Fu XD ( 2007) SR proteins and related factors in alternative splicing. Adv Exp Med Biol 623: 107–122.
  • 49
    Luo H, Chen J, Chen K, Shen X, Jiang H ( 2006) Carboxyl terminus of severe acute respiratory syndrome coronavirus nucleocapsid protein: self-association analysis and nucleic acid binding characterization. Biochemistry 45: 11827–11835.
  • 50
    Chang CK, Sue SC, Yu TH, Hsieh CM, Tsai CK, Chiang YC, Lee SJ, Hsiao HH, Wu WJ, Chang CF, Huang TH ( 2005) The dimer interface of the SARS coronavirus nucleocapsid protein adapts a porcine respiratory and reproductive syndrome virus-like structure. FEBS Lett 579: 5663–5668.
  • 51
    Luo H, Ye F, Chen K, Shen X, Jiang H ( 2005) SR-rich motif plays a pivotal role in recombinant SARS coronavirus nucleocapsid protein multimerization. Biochemistry 44: 15351–15358.
  • 52
    Sreerama N, Woody RW ( 1993) A self-consistent method for the analysis of protein secondary structure from circular dichroism. Anal Biochem 209: 32–44.
View Full Article with Supporting Information (HTML) Get PDF (468K)